TherapeuticsMD reported $6.7M in Stock for its fiscal quarter ending in September of 2022.





Stock Change Date
AbbVie USD 5.05B 98M Mar/2026
Cipla INR 61.6B 5.18B Sep/2025
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
Grifols EUR 3.56B 63.19M Dec/2024
Novo Nordisk DKK 42.85B 2B Mar/2025
Pfizer USD 10.67B 13M Mar/2026
TherapeuticsMD USD 6.7M 551K Sep/2022